Toll-Like Receptor 7 Staining in Malignant Epithelial Tumors

被引:1
|
作者
Franz, Regina [1 ]
Ritter, Nathalie [1 ]
Hein, Ruediger [1 ]
Biedermann, Tilo [1 ]
Al-Sisi, Mohammed [1 ]
Eyerich, Kilian [1 ]
Garzorz-Stark, Natalie [1 ]
Andres, Christian [1 ,2 ]
机构
[1] Tech Univ Munich, Dept Dermatol & Allergy, Munich, Germany
[2] Labor Dermatohistol, Sonnenstr 7, D-80331 Munich, Germany
基金
欧盟地平线“2020”;
关键词
Toll-like receptor 7; squamous cell carcinoma; basal cell carcinoma; basosquamous carcinoma; SQUAMOUS-CELL CARCINOMA; IMIQUIMOD; AGONIST; CANCER;
D O I
10.1097/DAD.0000000000000784
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: As important players of the innate immune system, Toll-like receptors (TLRs) and their role for tumorigenesis have been in the focus of research. In particular TLR7 is an interesting candidate, as TLR7 agonists are broadly used for the treatment of cutaneous tumors. However, data addressing the baseline expression of TLR7 in both basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) on the protein level are lacking, while on the genomic level significantly elevated expression of TLR7 in SCC but not in BCC has been demonstrated. Aim: Our aim was to characterize the immunohistochemical staining pattern of TLR7 in SCC and BCC. Besides, we aimed to clarify if, in case of different TLR7 expression between SCC and BCC, TLR7 expression would help to define basosquamous carcinoma (BSC), a tumor entity sharing characteristics of both SCC and BCC. Methods: We examined histopathological samples from 23 BCC, 4 BSC, and 24 SCC and characterized the expression of TLR7 by immunohistochemistry and immunofluorescence. Results: We found that TLR7 was not expressed by the tumor tissue of SCC, BCC, and BSC, but by inflammatory cells located within the tumoral and/or peritumoral tissue. Whereas the overall expression of TLR7 did not differ between BCC and SCC (30.4% vs. 45.8%, respectively), we found that within the group of SCC, the well-differentiated SCC showed strong tumoral and/or peritumoral immunocellular TLR7 reactivity in contrast to the poorly differentiated SCC (73.33% vs. 11.1%, respectively). Besides, immunofluorescence double staining revealed the expression of TLR7 in immune cells closely interacting with T cells and natural killer cells. Conclusions: In contrast to genomic data, we did not find a general difference between baseline TLR7 expression of SCC and BCC on the protein level. Nevertheless, the expression of TLR7 by the inflammatory infiltrate associated with SCC may correlate with the degree of differentiation of SCC possibly indicating better outcome.
引用
收藏
页码:742 / 746
页数:5
相关论文
共 50 条
  • [41] Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand
    Wu, Christina C. N.
    Hayashi, Tomoko
    Takabayashi, Kenji
    Sabet, Mojgan
    Smee, Donald F.
    Guiney, Donald D.
    Cottam, Howard B.
    Carson, Dennis A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (10) : 3990 - 3995
  • [42] The nucleotide-sensing Toll-Like Receptor 9/Toll-Like Receptor 7 system is a potential therapeutic target for IgA nephropathy
    Lee, Mingfeng
    Suzuki, Hitoshi
    Ogiwara, Kei
    Aoki, Ryosuke
    Kato, Rina
    Nakayama, Maiko
    Fukao, Yusuke
    Nihei, Yoshihito
    Kano, Toshiki
    Makita, Yuko
    Muto, Masahiro
    Yamada, Koshi
    Suzuki, Yusuke
    KIDNEY INTERNATIONAL, 2023, 104 (05) : 943 - 955
  • [43] Toll-like Receptor 7 Rapidly Relaxes Human Airways
    Drake, Matthew G.
    Scott, Gregory D.
    Proskocil, Becky J.
    Fryer, Allison D.
    Jacoby, David B.
    Kaufman, Elad H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (06) : 664 - 672
  • [44] Toll-like Receptor 7 on Airway Nerves Causes Bronchodilation
    Drake, Matthew Georgenson
    Proskocil, Becky J.
    Lebold, Katherine
    Blum, Emily
    Fryer, Allison
    Jacoby, David
    FASEB JOURNAL, 2016, 30
  • [45] Toll-like receptor-7 tolerizes malignant B cells and enhances killing by cytotoxic agents
    Shi, Yonghong
    White, Dionne
    He, Liwei
    Neher, Richard L.
    Spaner, David E.
    CANCER RESEARCH, 2007, 67 (04) : 1823 - 1831
  • [46] Toll-like receptor 7 regulates osteoclastogenesis in rheumatoid arthritis
    Kim, Kyoung-Woon
    Kim, Bo-Mi
    Won, Ji-Yeon
    Lee, Kyung-Ann
    Kim, Hae-Rim
    Lee, Sang-Heon
    JOURNAL OF BIOCHEMISTRY, 2019, 166 (03): : 259 - 270
  • [47] Toll-like receptor 7 signaling drives IgA responses
    Bessa, J.
    Jegerlehner, A.
    Bachmann, M. F.
    SWISS MEDICAL WEEKLY, 2007, 137 : 16S - 16S
  • [48] Decreased Toll-Like Receptor 2 and Toll-Like Receptor 7/8-Induced Cytokines in Parkinson's Disease Patients
    da Silva, Delson Jose
    Borges, Arissa Felipe
    Souza, Priscila Oliveira
    de Souza, Patricia Reis
    de Barros Cardoso, Cristina Ribeiro
    Dorta, Miriam Leandro
    Pelli de Oliveira, Milton Adriano
    Teixeira, Antonio Lucio
    Ribeiro-Dias, Fatima
    NEUROIMMUNOMODULATION, 2016, 23 (01) : 58 - 66
  • [49] THE TOLL-LIKE RECEPTOR 7 AGONIST IMIQUIMOD INCREASES ETHANOL SELF-ADMINISTRATION AND INDUCES EXPRESSION OF TOLL-LIKE RECEPTOR 3
    Lovelock, D. F.
    Langston, S. E.
    Liu, W.
    Van Voorhies, K.
    Vetreno, R. P.
    Crews, F. T.
    Besheer, J.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2020, 44 : 30 - 30
  • [50] Toll-Like Receptor Signaling
    Lim, Kian-Huat
    Staudt, Louis M.
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2013, 5 (01):